Table Of Content |
Impacts of Nanotechnology on Biomedicine Introduction to Biomedical Nanotechnology; Dorothy Farrell, George Hinkal, and Piotr Grodzinski Impact of Bionanointeractions of Engineered Nanoparticles for Nanomedicine; Stefania Sabella Rational Approach for the Safe Design of Nanomaterials; Anna L. Costa Characterization of Manufactured Nanomaterials, Dispersion, and Exposure for Toxicological Testing; Keld A. Jensen, Giulio Pojana, and Dagmar Bilaničová Exposure Workplace Inhalation Exposure to Engineered Nanomaterials: Detection, Measurement, and Assessment; Araceli Sánchez Jiménez, Derk Brouwer, and Martie Van Tongeren Nanotechnology in Consumer Products: Addressing Potential Health and Safety Implications for Consumers; Treye A. Thomas Modeling Quantitative Nanostructure–Activity Relationships: From Unstructured Data to Predictive Models for Designing Nanomaterials with Controlled Properties; Denis Fourches and Alexander Tropsha Pharmacokinetics and Biodistribution of Nanomaterials; Jim E. Riviere Methodologies and Techniques Advanced Methodologies and Techniques for Assessing Nanomaterial Toxicity: From Manufacturing to Nanomedicine Screening; Adriele Prina-Mello, Bashir M. Mohamed, Navin K. Verma, Namrata Jain, and Yuri Volkov Detection Methods for the In Vivo Biodistribution of Iron Oxide and Silica Nanoparticles: Effects of Size, Surface Chemistry, and Shape; Heather A. Enright and Michael A. Malfatti Quantitative Single-Cell Approaches to Assessing Nanotoxicity in Nanomedicine Systems; James F. Leary Imaging Techniques for Nanoparticles in Skin; Tarl W. Prow Hazards Safety Implications of Nanomaterial Exposure to Skin; Nancy A. Monteiro-Riviere Interspecies Comparisons of Pulmonary Responses to Fine and/or Nanoscale Particulates: Relevance for Humans of Particle-Overload Responses in the Rat Model; David B. Warheit and Kenneth L. Reed Current In Vitro Models for Nanomaterial Testing in Pulmonary Systems; Sonja Boland, Sandra Vranic, Roel Schins, and Tobias Stöger Nanoparticles and the Immune System; Bengt Fadeel and Diana Boraschi Carbon Nanotubes and Cardiovascular Disease; Peter Møller, Cao Yi, Lise K. Vesterdal, Pernille H. Danielsen, Martin Roursgaard, Henrik Klingberg, Daniel V. Christophersen, and Steffen Loft Single- and Multi-walled Carbon Nanotubes Toxicity and Potential Applications in Neuroregeneration; Fariborz Tavangarian, Guoqiang Li, and Yiyao Li Current In Vitro Models for Nanomaterial Testing: The Reproductive System; Gary R. Hutchison and Bryony L. Ross Current In Vitro Models for Nanomaterial Testing: Genotoxicity Issues; Laetitia Gonzalez, Sara Corradi, and Micheline Kirsch-Volders Cell-Based Targeting of Anticancer Nanomaterials to Tumors; Matt Basel, Tej Shrestha, Hongwang Wang, and Stefan Bossmann Silver Nanoparticles in Biomedical Applications; Meghan E. Samberg and Nancy A. Monteiro-Riviere Cytotoxicity of Conjugated and Unconjugated Semiconductor and Metal Nanoparticles; Jay Nadeau Risk Assessment Issues Related to Risk Assessment of Nanomaterials; Maureen R. Gwinn Risk Assessment of Engineered Nanomaterials: State of the Art and Roadmap for Future Research; Danail Hristozov, Laura MacCalman, Keld A. Jensen, Vicki Stone, Janeck Scott-Fordsmand, Bernd Nowack, Teresa Fernandes, and Antonio Marcomini Index
|